PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Targeting the protein-making machinery to stop harmful bacteria

2014-09-07
(Press-News.org) One challenge in killing off harmful bacteria is that many of them develop a resistance to antibiotics. Researchers at the University of Rochester are targeting the formation of the protein-making machinery in those cells as a possible alternate way to stop the bacteria. And Professor of Biology Gloria Culver has, for the first time, isolated the middle-steps in the process that creates that machinery—called the ribosomes.

"No one had a clear understanding of what happened inside an intact bacterial cell," said Culver, "And without that understanding, it would not be possible to block ribosome formation as a new means of stopping bacterial growth."

Since proteins are essential for life, organisms would die-off if not allowed to manufacture proteins.

Culver's work has been published in Nature Structural and Molecular Biology.

Ribosomes are made of ribonucleic acid (RNA) and protein molecules that fit together like pieces of a puzzle. In order for the puzzle to work, the strands of RNA molecules need to be pared down to the right size. This multi-step process happens very quickly, making it difficult to capture a piece of ribosomal RNA in one of the intermediate states. Culver and graduate student Neha Gupta have managed to do just that by using genetic tags as markers inside E. coli cells.

By attaching the tags to non-functional regions of the uncut RNA, the researchers were able to isolate the immature RNA strands during the various stages of processing. On analyzing the intermediate fragments, Culver and Gupta found that ribosomal RNA does not follow a single sequential series of steps. While there appears to be an early common step, some of the intermediate RNA strands had started losing fragments from one side, while other intermediate RNAs at a similar stage were being cleaved from the other side. The different pathways of processing the RNA take place simultaneously among the various molecules, resulting in RNA strands being able to fit together with protein molecules to form fully-developed ribosomes.

Targeting ribosomes to kill drug-resistant bacteria is nothing new, except, in the past, scientists focused on mature ribosomes. While a range of antibiotics were developed to attack the ribosomes, the microbes eventually became resistant to those drugs.

While Culver's work creates new possibilities for stopping super-bugs, a great deal of work remains to be done.

"If bacterial cells have more than one way to make ribosomes, blocking just one pathway may not be enough to kill them." said Culver. "But our discoveries suggest that there is at least one common step that could be exploited to one day help scientists prevent the ribosomes from developing, which would kill off the bacteria." INFORMATION:


ELSE PRESS RELEASES FROM THIS DATE:

Continuing Bragg legacy of structure determination

2014-09-07
Over 100 years since the Nobel Prize-winning father and son team Sir William and Sir Lawrence Bragg pioneered the use of X-rays to determine crystal structure, University of Adelaide researchers have made significant new advances in the field. Published in the journal Nature Chemistry today, Associate Professors Christian Doonan and Christopher Sumby and their team in the School of Chemistry and Physics, have developed a new material for examining structures using X-rays without first having to crystallise the substance. "2014 is the International Year of Crystallography, ...

Ultraviolet light-induced mutation drives many skin cancers, Stanford researchers find

2014-09-07
A genetic mutation caused by ultraviolet light is likely the driving force behind millions of human skin cancers, according to researchers at the Stanford University School of Medicine. The mutation occurs in a gene called KNSTRN, which is involved in helping cells divide their DNA equally during cell division. Genes that cause cancer when mutated are known as oncogenes. Although KNSTRN hasn't been previously implicated as a cause of human cancers, the research suggests it may be one of the most commonly mutated oncogenes in the world. "This previously unknown oncogene ...

Ultra-thin, high-speed detector captures unprecedented range of light waves

Ultra-thin, high-speed detector captures unprecedented range of light waves
2014-09-07
New research at the University of Maryland could lead to a generation of light detectors that can see below the surface of bodies, walls, and other objects. Using the special properties of graphene, a two-dimensional form of carbon that is only one atom thick, a prototype detector is able to see an extraordinarily broad band of wavelengths. Included in this range is a band of light wavelengths that have exciting potential applications but are notoriously difficult to detect: terahertz waves, which are invisible to the human eye. A research paper about the new detector ...

Researchers discover a key to making new muscles

Researchers discover a key to making new muscles
2014-09-07
La Jolla, Calif., September 7, 2014 -- Researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) have developed a novel technique to promote tissue repair in damaged muscles. The technique also creates a sustainable pool of muscle stem cells needed to support multiple rounds of muscle repair. The study, published September 7 in Nature Medicine, provides promise for a new therapeutic approach to treating the millions of people suffering from muscle diseases, including those with muscular dystrophies and muscle wasting associated with cancer and aging. There ...

UK study identifies molecule that induces cancer-killing protein

2014-09-07
LEXINGTON, Ky. (Sept. 8, 2014) – A new study by University of Kentucky researchers has identified a novel molecule named Arylquin 1 as a potent inducer of Par-4 secretion from normal cells. Par-4 is a protein that acts as a tumor suppressor, killing cancer cells while leaving normal cells unharmed. Normal cells secrete small amounts of Par-4 on their own, but this amount is not enough to kill cancer cells. Notably, if Par-4 secretion is suppressed, this leads to tumor growth. Published in Nature Chemical Biology, the UK study utilized lab cultures and animal models ...

Each day in the hospital raises risk of multidrug-resistant infection

2014-09-07
If a patient contracts an infection while in the hospital, each day of hospitalization increases by 1% the likelihood that the infection will be multidrug-resistant, according to research presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) an infectious disease meeting of the American Society for Microbiology. Researchers from the Medical University of South Carolina gathered and analyzed historical data from 949 documented cases of Gram-negative infection at their academic medical center. In the first few days of hospitalization ...

New antifungal as effective as existing drugs with fewer adverse events

2014-09-07
A newly developed antifungal, isavuconazole, is as effective as an existing drug, voriconazole, against invasive mold disease in cancer patients with less adverse effects, according to phase 3 clinical data presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, an infectious disease meeting of the American Society for Microbiology. "There is a growing need for new antifungal therapies like isavuconazole because serious fungal infections caused by Aspergillus and other molds are on the rise due to the increasing numbers of immunosuppressed ...

Inexpensive lab test identifies resistant infections in hours

2014-09-07
Researchers from Oregon State Public Health Lab have modified the protocol for a relatively new test for a dangerous form of antibiotic resistance, increasing its specificity to 100 percent. Their research, confirming the reliability of a test that can provide results in hours and is simple and inexpensive enough to be conducted in practically any clinical laboratory was presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, an infectious disease meeting of the American Society for Microbiology. The test, called Carba NP, originally ...

61 percent fall in female genital warts due to free HPV vaccine

61 percent fall in female genital warts due to free HPV vaccine
2014-09-07
GPs in Australia are managing 61 per cent less cases of genital warts among young women since the introduction of the national human papillomavirus (HPV) vaccination program, a new study from the University of Sydney reveals. The study, which reviewed more than a million patient encounters between 2000 and 2012, showed a significant year-on-year reduction in the management rate of genital warts in women aged 15-27 years since the vaccination program started. The findings are published in PLOS One journal. "The results show that the program has been a widespread success," ...

Flour identified as the main cause of occupational asthma in France

2014-09-07
Munich, Germany: Flour has been identified as the main cause of occupational asthma in France, closely followed by cleaning products. A new study, which was presented at the European Respiratory Society's International Congress today (07 September 2014), analysed all cases of occupational asthma in France. The research, which is the largest of its kind to be undertaken in France, aimed to understand who was most affected by the condition and what the main causes were. Data were collected over a 3-year period from a network of respiratory doctors specialised in occupational ...

LAST 30 PRESS RELEASES:

‘How drunk do you feel?’: Ozempic, Wegovy may help reduce alcohol use, Virginia Tech researchers find

Divine punishment as an ancient tool for modern sustainability

Hotter does mean wetter

Internal migrants in the U.S. age with fewer disabilities, study finds

Anna Krylov and Mikhail Yampolsky are the new George Gamow award laureates

Methane from overlooked sources higher than predicted in Osaka

World’s largest rays may be diving to extreme depths to build mental maps of vast oceans

Can we hear gravitational-wave "beats" in the rhythm of pulsars?

New survey shows many are unaware of advancements in obstetrics care

New combination therapy shows promise for aggressive lymphoma resistant to immunotherapy

Photocatalytic olefin double bond cleavage acylation

Unveiling the impact of compound drought and wildfire events on PM2.5 air pollution in the era of climate change

A bioadhesive sponge inspired by mussels and extracellular matrix offers a new way to stop internal bleeding

Poorer health linked to more votes for Reform UK, 2024 voting patterns suggest

Loneliness and social isolation linked to heightened risk of death in those with cancer

Ditch ‘shrink it and pink it’ approach to women’s running shoes, manufacturers urged

Domestic abusers forge ‘trauma bonds’ with victims before violence begins

UK food needs radical transformation on scale not seen since Second World War, new report finds

New AI tool makes medical imaging process 90% more efficient

Nitrogen-fortified nanobiochar boosts soil health and rice productivity

Generative art enhances virtual shopping experience

Fluid-based laser scanning for brain imaging

Concordia study links urban heat in Montreal to unequal greenspace access

Hidden patterns link ribosomal RNAs to genes of the nervous system

Why does losing the Y chromosome make some cancers worse? New $6.5 million NIH grant could provide clues

Xiao receives David W. Robertson Award for Excellence in Medicinal Chemistry

Boron isotopes reveal how nuclear waste glass slowly dissolves over time

Biochar helps Mediterranean vineyards hold water and fight erosion

Checking the quality of materials just got easier with a new AI tool

Does hiding author names make science fairer?

[Press-News.org] Targeting the protein-making machinery to stop harmful bacteria